{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:27:42Z","timestamp":1794302862614,"version":"4.9.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ajo.2026.09.020","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:22:20Z","timestamp":1789773740000},"page":"645-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Predictors of Vision Loss and Surgical Intervention in Stevens\u2013Johnson Syndrome: A Multicenter Nationwide Cohort Study"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4217-8985","authenticated-orcid":false,"given":"GUSTAVO","family":"ORTIZ-MORALES","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6757-819X","authenticated-orcid":false,"given":"RAUL HERNAN","family":"BARCELO-CANTON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1419-2109","authenticated-orcid":false,"given":"ALEJANDRO","family":"RODRIGUEZ-GARCIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARIANA","family":"FERNANDEZ-ALDRETE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NALLELY","family":"RAMOS-BETANCOURT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1856-3200","authenticated-orcid":false,"given":"FERNANDO","family":"PENICHE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0081-7745","authenticated-orcid":false,"given":"LUZ ELENA","family":"CONCHA-DEL-RIO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8252-5924","authenticated-orcid":false,"given":"KARIM","family":"MOHAMED-NORIEGA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FERNANDO","family":"MORALES-WONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DENISE","family":"LOYA-GARCIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6419-5116","authenticated-orcid":false,"given":"ARTURO","family":"RAMIREZ-MIRANDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7463-1599","authenticated-orcid":false,"given":"JAMES","family":"CHODOSH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ENRIQUE O.","family":"GRAUE-HERNANDEZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajo.2026.09.020_bib0001","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1398-9995.2006.01295.x","article-title":"Ocular Manifestations and Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: an Asian Series","volume":"62","author":"Yip","year":"2007","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.020_bib0002","doi-asserted-by":"crossref","DOI":"10.1097\/ICU.0000000000000312","article-title":"Ocular manifestations of Stevens-Johnson Syndrome and their management","volume":"27","author":"Saeed","year":"2016","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.020_bib0003","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajo.2015.05.002","article-title":"Predictive factors associated with acute ocular involvement in Stevens-Johnson Syndrome and toxic epidermal necrolysis","volume":"160","author":"Sotozono","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.020_bib0004","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/jbcr\/irae140","article-title":"Utility of the severity-of-illness score for toxic epidermal necrolysis (SCORTEN) in pediatric Stevens-Johnson Syndrome patients","volume":"46","author":"Gust","year":"2025","journal-title":"J Burn Care Res"},{"issue":"3","key":"10.1016\/j.ajo.2026.09.020_bib0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jtos.2020.03.004","article-title":"Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome\/Toxic epidermal necrolysis","volume":"18","author":"Shanbhag","year":"2020","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.020_bib0006","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ophtha.2008.12.048","article-title":"Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications","volume":"116","author":"Sotozono","year":"2009","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.020_bib0007","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","article-title":"A marker for Stevens-Johnson Syndrome...: ethnicity matters","volume":"6","author":"Lonjou","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.ajo.2026.09.020_bib0008","series-title":"StatPearls [Internet]","article-title":"Stevens-Johnson syndrome","author":"Oakley","year":"2023"},{"key":"10.1016\/j.ajo.2026.09.020_bib0009","article-title":"Severe ocular complications of SJS\/TEN and associations among pre-onset, acute, and chronic factors: a report from the international ophthalmology collaborative group","volume":"10","author":"Ueta","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.020_bib0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.020_bib0011","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/bjd\/ljae321","article-title":"Recent progress in Stevens-Johnson syndrome\/toxic epidermal necrolysis: diagnostic criteria, pathogenesis and treatment","volume":"192","author":"Hama","year":"2024","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.ajo.2026.09.020_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bjophthalmol-2019-314928","article-title":"Clinical clues predictive of Stevens-Johnson syndrome as the cause of chronic cicatrising conjunctivitis","volume":"104","author":"Shanbhag","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2026.09.020_bib0013","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/ICO.0000000000002358","article-title":"Global consensus on the management of limbal stem cell deficiency","volume":"39","author":"Deng","year":"2020","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.020_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2025.101145","article-title":"An international scoping review of epidemiologic studies on severe cutaneous adverse reactions","volume":"19","author":"Lee","year":"2026","journal-title":"World Allergy Organ J"},{"issue":"3","key":"10.1016\/j.ajo.2026.09.020_bib0015","doi-asserted-by":"crossref","DOI":"10.3341\/kjo.2020.0118","article-title":"Acute and chronic ophthalmic involvement, severity, and sequelae in Stevens-Johnson Syndrome and toxic epidermal necrolysis","volume":"35","author":"Ganekal","year":"2021","journal-title":"Korean J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.09.020_bib0016","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3341\/kjo.2013.27.5.331","article-title":"Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome","volume":"27","author":"Kim","year":"2013","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.09.020_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2018.10.016","article-title":"Corneal limbal stem cell deficiency in children with Stevens-Johnson Syndrome","volume":"199","author":"Choi","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.09.020_bib0018","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ajo.2023.08.009","article-title":"Ocular manifestations and outcomes in children with Stevens-Johnson Syndrome and toxic epidermal necrolysis: a comparison with adult patients","volume":"256","author":"Chen","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.09.020_bib0019","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ajo.2020.07.006","article-title":"Lid-related keratopathy in Stevens-Johnson Syndrome: natural course and impact of therapeutic interventions in children and adults","volume":"219","author":"Shanbhag","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.020_bib0020","doi-asserted-by":"crossref","DOI":"10.1007\/s40257-021-00661-0","article-title":"Culprit medications and risk factors associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: population-based nested case-control study","volume":"23","author":"Gronich","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"7","key":"10.1016\/j.ajo.2026.09.020_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.burns.2021.08.009","article-title":"Review of culprit drugs associated with patients admitted to the burn unit with the diagnosis of Stevens-Johnson Syndrome and toxic epidermal necrolysis syndrome","volume":"48","author":"de Bustros","year":"2022","journal-title":"Burns"},{"key":"10.1016\/j.ajo.2026.09.020_bib0022","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review of PubMed\/MEDLINE case reports from 1980 to 2020","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.020_bib0023","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaci.2020.08.003","article-title":"Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians","volume":"147","author":"Wang","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.ajo.2026.09.020_bib0024","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jama.2014.7859","article-title":"Genetic variants associated with phenytoin-related severe cutaneous adverse reactions","volume":"312","author":"Chung","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.020_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2025.107524","article-title":"Association of antibiotics with Stevens-Johnson syndrome and toxic epidermal necrolysis: a real-world pharmacovigilance study","volume":"66","author":"Yan","year":"2025","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajo.2026.09.020_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2087578","article-title":"Factors contributing to long-term severe visual impairment in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"2017","author":"Jongkhajornpong","year":"2017","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.020_bib0027","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s40001-025-02664-7","article-title":"Recent developments in the research of Stevens-Johnson syndrome and toxic epidermal necrolysis: pathogenesis, diagnosis and treatment","volume":"30","author":"Yao","year":"2025","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.ajo.2026.09.020_bib0028","article-title":"Independent strong association of HLA-A02:06 and HLA-B44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement","volume":"4","author":"Ueta","year":"2014","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.020_bib0029","doi-asserted-by":"crossref","DOI":"10.4168\/aair.2019.11.2.212","article-title":"Phenotypes of severe cutaneous adverse reactions caused by nonsteroidal anti-inflammatory drugs","volume":"11","author":"Lee","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.ajo.2026.09.020_bib0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jtos.2022.03.005","article-title":"The evolution of the modified osteo-odonto-keratoprosthesis, its reliability, and long-term visual rehabilitation prognosis: an analytical review","volume":"24","author":"Ortiz-Morales","year":"2022","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2026.09.020_bib0031","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/ICO.0000000000002532","article-title":"Ocular sequelae of Stevens-Johnson Syndrome: a comprehensive approach","volume":"39","author":"Iyer","year":"2020","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2026.09.020_bib0032","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00417-014-2568-8","article-title":"Comprehensive approach to ocular consequences of Stevens Johnson Syndrome - the aftermath of a systemic condition","volume":"252","author":"Iyer","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2026.09.020_bib0033","first-page":"1","article-title":"The role of the Boston keratoprosthesis in severe ocular surface disease and autoimmune diseases","volume":"19","author":"Ortiz-Morales","year":"2026","journal-title":"Semin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.020_bib0034","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.survophthal.2016.01.004","article-title":"Stevens-Johnson syndrome: the role of an ophthalmologist","volume":"61","author":"Jain","year":"2016","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.09.020_bib0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jtos.2016.02.001","article-title":"Acute and chronic ophthalmic involvement in Stevens-Johnson Syndrome\/toxic epidermal necrolysis - A comprehensive review and guide to therapy. II. Ophthalmic disease","volume":"14","author":"Kohanim","year":"2016","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.020_bib0036","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/ICO.0000000000002263","article-title":"Long-term progression of ocular surface disease in Stevens-Johnson Syndrome and toxic epidermal necrolysis","volume":"39","author":"Yoshikawa","year":"2020","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.020_bib0037","doi-asserted-by":"crossref","DOI":"10.1097\/ICO.0000000000000680","article-title":"Treatment modalities and clinical outcomes in ocular sequelae of Stevens-Johnson syndrome over 25 years: a paradigm shift","volume":"35","author":"Iyer","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2026.09.020_bib0038","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajo.2018.01.028","article-title":"Chronic ocular sequelae of Stevens-Johnson syndrome in children: long-term impact of appropriate therapy on natural history of disease","volume":"189","author":"Basu","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.020_bib0039","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4103\/ijo.IJO_1273_20","article-title":"A beginner's guide to mucous membrane grafting for lid margin keratinization: review of indications, surgical technique and clinical outcomes","volume":"69","author":"Shanbhag","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.020_bib0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajo.2014.03.012","article-title":"Prosthetic replacement of the ocular surface ecosystem scleral lens therapy for patients with ocular symptoms of chronic Stevens-Johnson Syndrome","volume":"158","author":"Heur","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.09.020_bib0041","doi-asserted-by":"crossref","first-page":"73","DOI":"10.51329\/mehdiophthal1525","article-title":"Scleral lenses and PROSE: indications, complications, and future challenges","volume":"14","author":"Rodriguez-Garcia","year":"2025","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.09.020_bib0042","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/vision9030078","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review of ophthalmic management and treatment","volume":"9","author":"Sawires","year":"2025","journal-title":"Vision (Basel)"},{"issue":"8","key":"10.1016\/j.ajo.2026.09.020_bib0043","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/bjo.2006.109124","article-title":"The natural history of Stevens Johnson Syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy","volume":"91","author":"De Rojas","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.09.020_bib0044","article-title":"Understanding immune responses to surgical transplant procedures in Stevens Johnsons Syndrome patients","volume":"8","author":"Soifer","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.020_bib0045","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/ICO.0b013e31823f8b0c","article-title":"Systemic Immunosuppression in ocular surface stem cell transplantation: results of a 10-year experience","volume":"31","author":"Holland","year":"2012","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.020_bib0046","first-page":"23","article-title":"Systemic immunosuppression for limbal allograft and allogenic limbal epithelial cell transplantation","volume":"9","author":"Serna-Ojeda","year":"2020","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.020_bib0047","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.09.020_bib0048","article-title":"Clinical aspects of Stevens-Johnson syndrome and toxic epidermal necrolysis with severe ocular complications in South Korea","volume":"8","author":"Kim","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajo.2026.09.020_bib0049","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jtos.2025.10.002","article-title":"Amniotic membrane transplantation techniques in acute ocular Stevens-Johnson Syndrome and toxic epidermal necrolysis: a Systematic Review","volume":"38","author":"Paris","year":"2025","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2026.09.020_bib0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ajo.2019.07.006","article-title":"Long-term effect of a treatment protocol for acute ocular involvement in Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"208","author":"Shanbhag","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.09.020_bib0051","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s40123-023-00725-w","article-title":"Ophthalmic aspects of Stevens-Johnson syndrome and toxic epidermal necrolysis: a narrative review","volume":"12","author":"T\u00f3th","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"6","key":"10.1016\/j.ajo.2026.09.020_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198582","article-title":"Life-threatening dermatoses: Stevens-Johnson syndrome and toxic epidermal necrolysis. Impact on the Spanish Public Health System (2010-2015)","volume":"13","author":"Velasco-Tirado","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ajo.2026.09.020_bib0053","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/bjd\/ljad234","article-title":"Lifetime risk, life expectancy, loss-of-life expectancy and lifetime healthcare expenditure for Stevens-Johnson syndrome\/toxic epidermal necrolysis in Taiwan: follow-up of a nationwide cohort from 2008 to 2019","volume":"189","author":"Chiu","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajo.2026.09.020_bib0054","article-title":"Updates in SJS\/TEN: collaboration, innovation, and community","volume":"10","author":"Marks","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.ajo.2026.09.020_bib0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamadermatol.2025.4345","article-title":"Recovering from Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"162","author":"Martin-Pozo","year":"2026","journal-title":"JAMA Dermatol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426005222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426005222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T09:05:51Z","timestamp":1794301551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426005222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":55,"alternative-id":["S0002939426005222"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.09.020","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of Vision Loss and Surgical Intervention in Stevens\u2013Johnson Syndrome: A Multicenter Nationwide Cohort Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}